Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Bichile, S. K.
- Thrombocytopenia in Acute Febrile Illness
Abstract Views :183 |
PDF Views:1
Authors
Source
The Indian Practitioner, Vol 69, No 8 (2016), Pagination: 7-8Abstract
Febrile illness of two weeks or shorter is considered as acute febrile illness. Acute febrile illness is also referred as acute undifferentiated fever because of its short duration and absence of clinical features pointing to organ specific illness. There is no international consensus definition however, fever patients with localizing symptoms and signs are excluded e.g., acute pneumonia, acute meningitis, acute urinary tract infection etc.
References
- Joshi R, Kalantri S.P. Acute undifferentiated fever: Management algorithm www.-apiindia.org/pdf/fever 001_ acute__undifferentiatedfever_pdf.
- Bajpai S, Bichile L.S Mortality analysis of patients of acute febrile illness during monsoon in a tertiary care hospital Inf. Dis in clinical practice DOI.10.1097/IPC.obo13e31817 efd66
- Narvenkar K.P, Rodrigues S, Nevrekar RP et al. Scrub typhus in patients with acute febrile illness at a tertiary care institution in Goa Indian J Medical research 2012; 136(6):1020-4)
- Kothari VM, Karnad DR, Bichile LS - Tropical infections in ICU J. Asso. Physicians of India 2006;54:291-8
- Varghese GM, Abraham OC, Mathai D et. al. Scrub typhus amongst hospitalised patients with febrile illness in South India Magnitude and clinical predictors J.Infect 2006;52.5660
- Sharma A, Mahajan S, Gupta ML et al Investigation of an outbreak of scrub typhus in Himalayan region of India Jpn. J.Infect.Dis. 2005; 58:208-10
- Busch MP - HIV, HBV, HCV New developments related to transfusion safety Vox Sang 2000;78(suppl ) 2:253-56
- Kshirsagar P, Chauhan S, Samel D. Towards developing scoring system J Assoc Phys. India 2016;63:14-18.
- Shantakumari B, DS Somsekar, Bharat G, and Gairik Kundu. A survey of pseudothrombocytopenia Journal of evidenced based medicine and health care 2014;118:22.
- Mayxay M, Castonguay VJ, Chansamouth V et al. Causes of no malarial fever in Laos: a prospective study. The Lancet Global health 2013; 1910:e 46-54
- Leowattana W, Tanapukakdee N, Thar SK et al. Changes in platelet count in uncomplicated and severe falciparum malaria South East Asian J. Trop.Med. Public Health 2010; 41(5) :1035-41
- Shivbalan S, Anandnathan K, Balasubramanian et al. Predictors of spontaneous bleeding in Dengue Indan J Pediatr 2004;71:33-36).
- Kumar ND, Tomar V, Singh B, Kela K. Management of dengue fever (DHF/DSS) during dengue epidemic Ind.J.Pathol. Microbiol. 2000;43:55-60
- Makroo RN, Raina V, Kumar P, Kanth RK. Role of platelet transfusion in management of dengue patients in a tertiary care hospital. Asian J. Transf. Sci 2007; 1:4-7
- Editorial
Abstract Views :185 |
PDF Views:0
Authors
Source
The Indian Practitioner, Vol 69, No 9 (2016), Pagination: 7-10Abstract
Allogenic (patient receives stem cells from a matching donor, either a sibling or an unrelated donor) hematopoietic stem cell therapy (HCT) is consid ered as standard therapy in selected patients suffering from hematopoetic malignancies, disorders of immune system, inherited metabolic disorders and solid tumors of non hematological and immune system (about 55 disorders are included in this category).References
- Parents guidecordblood.org/en/diseases
- McGuckin & Forraz Umbilical cord blood stem cellsan ethical source for regenerative medicine Med Law. 2008 ; 27(1):147-65.
- Gunning J Umbilical cord cell banking: an issue of selfinterest versus altruism. Med Law. 2007; 26(4):769-80.
- Gluckman E, Broxmeger HA,Auerbach G. Human Umbilical cord blood as potential source of transplantable hematopoietic progenitor cells Proc. Natl. Acad. Sci 1989.86:3828-32
- Ballen KK . Advances in umbilical cord blood transplantation. Curr.Stem. Cell. Res.Ther. 2006; 1(3); 31724
- Gonzalez-Ryan L, Van Syckle K, Coyne KD, Glover N Umbilical cord blood banking: procedural and ethical concerns for this new birth option.Pediatr Nurs. 2000 Jan-Feb; 26(1):105-10.
- Sullivan MJ .Banking on cord blood stem cells Nat. Rev. Cancer 2008; 8(7):555-63
- Ballen KK,Barker Jn, Stewart SK et al Collection and preservation of cord blood for personal use Biol Blood Marrow Transplant 2008;14: 356-63
- Sideri A,Neokleous N,De La Grange PB. Et al An over view of progress on double umbilical cord blood transplantation Hematologica 2011;96(8):1213-20
- Horwitz ME,Frassoni F . Improving outcome of umbilical cord blood transplantation through ex vi vo expansion or graftr manipulation . Cytotherapy 2015; 17(6):730-38
- Hu K,Yu J,Suknuntha K et al. Efficient generation of transgenic free induced pleuripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells . Blood; 117:e109-e119
- Renece Waller Wise. Umbilical cord blood – Information to child birth education. J.Perinatal Edu 2011;20(1):54-60)
- Moise KJ Jr Umbilical cord stem cells.Obstet Gynecol. 2005 Dec; 106(6):1393-407
- World’s first public private cord blood bank BMJ 2007; doi:http://dx.doi.org/10.1136/bmj.39115.513762.DB
- ACOG committee opinion number 399, February 2008: umbilical cord blood banking.Committee on Obstetric Practice, Committee on GeneticsObstet Gynecol. 2008 Feb; 111(2 Pt 1):475-7.
- Cord blood banking for potential future transplantation. American Academy of Pediatrics Section on Hematology/Oncology, American Academy of Pediatrics Section on Allergy/Immunology, Lubin BH, Shearer WTPediatrics. 2007 Jan; 119(1):165-70
- Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe SPediatrics. 2009 Mar; 123(3):1011-7
- Lothian J., & DeVries C. (2010). The official Lamaze guide: Giving birth with confidence (2nd ed.). New York, NY: Meadowbrook Press )3456
- Ballen KK. Advances in umbilical cord blood transplantation. Curr Stem Cell Res Ther. 2006 ; 1(3):317-24
- Drew D. Umbilical cord blood banking: A rich source of stem cells for transplant. Advance for Nurse Practitioners,2005; 13(Suppl. 4), S2–S7
- Choosing Wisely in Clinical Practice
Abstract Views :194 |
PDF Views:0
Authors
Source
The Indian Practitioner, Vol 69, No 10 (2016), Pagination: 7-8Abstract
National Academy of Science (US) published in 2005 that one third of spending in health care is wasteful. Miyakis et al reported that 27% of investigations done at the time of admission and 63% on subsequent days are avoidable. The American Board of Internal Medicine (ABIM) under auspices of ABIM Foundation launched in April 2012 with nine speciality societies an initiative with a goal of promoting discussions between physicians, patients and other public groups that would lead to avoidance of unnecessary tests, procedures and treatments and thus reduce waste in health care system. This initiative is called Choosing Wisely R campaign.- Blood Transfusion : Liberal or Restrictive ?
Abstract Views :228 |
PDF Views:0
Authors
Source
The Indian Practitioner, Vol 69, No 11 (2016), Pagination: 7-8Abstract
Transfusion of blood and blood components is used in therapy for many decades. It is frequently done on the assumption of the treating doctor that it will be beneficial to the patient. On many occasions this assumption may not be true and not supported by well designed randomised controlled trials. One of the early randomised trials in blood transfusion reported in 19991 was followed by many other randomised controlled trials.- New Paradigms in Treatment of Venous Thromboembolism
Abstract Views :167 |
PDF Views:0
Authors
Source
The Indian Practitioner, Vol 69, No 12 (2016), Pagination: 7-8Abstract
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are potentially serious clinical entities which can result in fatal outcome. Results of studies published have shown that DVT and PE (together referred as venous thromboembolism) in Indian patients are as much common as occurring amongst Western countries. Globally, incidence of VTE is 0.75-2.69 per 1000 population and in population 70 years or more incidence is 2-7 per 1000 population. However, the VTE risk perception amongst treating Indian physicians is variable and results in poor implementation of prophylaxis for thrombosis as compared to other countries. It has been reported that 53.6% of hospitalised patients (surgical 63.3%, medical 44.7%) were at risk of for VTE and more than 80% of these patients did not receive prophylaxis for VTE as recommended by American College of Physicians.References
- Pinjala RENDORSE-India investigators. Venous thromboembolism risk and prophylaxis in acute hospital care setting. a multinational cross sectional study : results from the Indian subset data. Indian J Med Res 2012;136:60-7
- Raskob GE, Angchalsuksiri P, Blanco AN, Buller H, GallusA, Hunt BJ et al Thrombosis a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014;34:2363-71
- Cohen AT. Tapson VF,Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B et al Venous thromboembolism risk and prophylaxis an the acute hospital care setting( ENDORSE study): a multinational cross sectional study Lancet 2008;371:387-94
- Schulman S, Lindmarker P, HO lmstrom M, Larfars G, Carlsson A, NicolP et al. Post thrombotic syndrome,recurrence and death 10 years after the first episode of venous thrombo embolism treated with warfarin for six weeks or six months J ThrombHaemost 2006;4:734-42
- Kakkar N, Kaur R, John M Outpatient oral anticoagulant management –an audit of 82 patients J Assoc Physicians India 2005;53:847-52
- Kakkar N, Kaur R Knowledge base of clinicians regarding oral anticoagulation therapy in teaching institution –a questionnaire survey J Assoc Physicians India 2004;52:868-72
- Yeh CH, Gross PL, Weitz JL Evolving use of new oral anticoagulantsfor treatment of venous thromboembolism Blood 2014;124(7):1020-28
- Moll S New insights into treatment of venous thromboembolism Hematology 2014;297-305
- Waldron B,Moll S A patients guideto recovery after deep vein thrombosis or pulmonary embolism Circulation 2014;129(17):e 477-e479
- Wells PS,Forgie MA,Rodger MA Treatment of venous thromboembolism JAMA 2014;311(7):717-28
- CohenAT,ImfeldS,Rider T Phase III trials of new oral anticoagulants i the acute treatment and secondary prevention of VTE:comparison and critique of study methodology and results Adv Ther 2014;31(5): 473-93
- Cushman M, Lim W, Zakai NA Clinical practice guide on anti thrombotic drug dosing and management of antithrombotic drug associated bleeding complications in adults http://www.hematology.org/ clinicians/guidelines-Quality/Quick-Ref/2869.aspx. September 14,2014
- Pollack CV, Relly PA, Elkelboom J, et al Idarucizumab for dabigatran reversal N Engl J Med 2015;373:511-20
- Kearan C, Omelas J, Blairas DO Anti thrombotic therapy for VTE disease Chest guidelines and expert panel report Chest 2016;149:315-52
- Simes J, Becanttini C, Agnelli G et al Aspirin for prevention of recurrent venous thromboembolism : the INSPIRE collaboration Circulation 2014;130(130:106271
- Mantha S, Karp R,Raghvan V et al Assessing the risk of venous thromboembolic events in women taking progestinonly cpntraception – a meta analysis BMJ 2012;345:e4944
- Kahn SR, Shapiro S,Wells PS et al Compression stockings to prevent post thrombotic syndrome a randomised placebo controlled trial Lancet 2014; 383(9920):880-88